Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a ...

Johnson & Johnson JNJ announced that the FDA has approved the subcutaneous (under the skin or SC) formulation of its EGFR/MET ...

The US Food and Drug Administration (FDA) has approved a pill version of the weight-loss drug Wegovy, according to pharmaceutical giant Novo Nordisk. It is the first pill of its kind to receive ...

Novo Nordisk shares rose 7.5% in early trading on Tuesday after the U.S. Food and Drug Administration approved its ...

The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy. Novo already sells an oral semaglutide for type 2 ...

T his past year, we explored a lot of new cell biology research—from cancer to plants to microbes, and more! It’s hard to ...

The U. S. Food and Drug Administration has approved an oral formulation of semaglutide for a new drug or biologic under the Prescription Drug User Fee Act. According to a news release, clinical trials ...

USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a ...

In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.

The reclassifications of marijuana mark the biggest change to the federal legality of it since 1970. Here's what's happening.

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily ...